Race/ethnicity and validity of self-reported pneumococcal vaccination
- Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial. Dagan, Ron; Patterson, Scott; Juergens, Christine; Greenberg, David; Givon-Lavi, Noga; Porat, Nurith; Gurtman, Alejandra; Gruber, William C.; Scott, Daniel A. // Clinical Infectious Diseases;Oct2013, Vol. 57 Issue 7, p952
The 13-valent pneumococcal conjugate vaccine compared with the 7-valent pneumococcal conjugate vaccine (PCV7) significantly reduced nasopharyngeal colonization of single serotypes 1, 6A, 6C, 7F, 19A, and 19F, but not serotype 3 or other PCV7 serotypes; serotype 5 had too few events for...
- Children Who Received PCV-10 Vaccine from a Two-Dose Vial without Preservative Are Not More Likely to Develop Injection Site Abscess Compared with Those Who Received Pentavalent (DPT-HepB-Hib) Vaccine: A Longitudinal Multi-Site Study. Berhane, Yemane; Worku, Alemayehu; Demissie, Meaza; Tesfaye, Neghist; Asefa, Nega; Aniemaw, Worku; Weldearegawi, Berhe; Kebede, Yigzaw; Shiferaw, Tigist; Worku, Amare; Olijira, Lemessa; Merdekios, Behailu; Ashebir, Yemane; Tadesse, Takele; Dessie, Yadeta; Meseret, Solomon; Ayele, Gestane // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1
Background: The single dose pneumonia ten-valent vaccine has been widely used and is highly efficacious against selected strains Streptococcus pneumonia. A two-dose vial without preservative is being introduced in developing countries to reduce the cost of the vaccine. In routine settings...
- Revaccinate against pneumococcal disease? Pinkowish, Mary Desmond // Patient Care;11/30/1994, Vol. 28 Issue 19, p90
Reports that older adults who received the 23-valent pneumococcal polysaccharide vaccine six or more years ago may need revaccination. Antibody determinations; Antibody levels against one third of the pneumococcal serotypes.
- Pneumococcal vaccine encore? M.O.R. // Cortlandt Forum;2/25/96, Vol. 9 Issue 2, p112
Responds to queries on administering pneumococcal polysaccharide vaccine. Age of vaccine administration; Recommendations for revaccination.
- Conjugate Pneumococcal Vaccines: Need and Choice in India. Malik, Akash // Indian Journal of Community Medicine;Oct-Dec2013, Vol. 38 Issue 4, p189
The authors reflect on the capability of pneumococcal vaccines as a public health tool to reduce the burden of pneumococcal diseases in developing countries including India. They discuss topics such as the common risk factors leading to the development of pneumonia, the interventions targeted on...
- Erratum. // Drugs;2012, Vol. 72 Issue 16, p2176
A correction to the article "Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed): In Older Adults" that was published in the June 2012 issue is presented.
- New vaccines for the prevention of pneumococcal infections. Kayhty, Helena; Eskola, Juhani // Emerging Infectious Diseases;Oct-Dec96, Vol. 2 Issue 4, p289
Provides information on the capsular polysaccharide vaccine, a vaccine used in the prevention of pneumococcal infections. Properties of the pathogenic bacteria Streptococcus pneumoniae (Pnc); Characteristics of pneumococcal protein vaccine candidates; Results from preclinical and clinical...
- Infant Vaccine Helps Seniors, Too. // AARC Times;Oct2013, Vol. 37 Issue 10, p79
The article discusses a Vanderbilt University research report published in the July 11, 2013 issue of "The New England Journal of Medicine" regarding the benefits of the infant vaccine against pneumococcal bacteria on older adults.
- Clarifications about pneumococcal vaccines. Morgenstern, Diana; Garcia-Curiel, Carmen S. // American Journal of Health-System Pharmacy;2/1/2010, Vol. 67 Issue 3, p183
A correction to an article on pneumococcal vaccine that was published in June 15, 2009 issue is presented.